fashion -WSS

fashion

author：comprehensive 2025-10-01 22:58:52 - browse：3

A drug developed by the biotech firm BridgeBio to treat an increasingly common heart condition succeeded in its main goal in a clinical trial, the company said Monday, and also pointed to potential reductions in hospitalization and death.

The results may give the medicine, acoramidis, a path to the market after a failure that led its maker’s stock to plunge in December 2021.

In the time since the initial failure, a rival Pfizer drug has become even more entrenched and another medicine, from Alnylam Pharmaceuticals, has had a successful clinical readout in the heart disease, known as ATTR-CM, in which a defective protein leads clumps to build up in the heart.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： What should King Charles tell the public about his cancer?

leisure time

explore

WSS

For Medicare Advantage, Democrats want stronger protections around AI

Medicare Advantage proposed rates disappoint insurers

The Readout: Gilead, Bernie Sanders, and other pharma news

Biotech stock slump in 2023: awaiting the turnaround

PhRMA lawsuit over Medicare drug price negotiation tossed

Thermo Fisher plant for manufacturing gene therapies to expand

explore

fashion

knowledge

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

Peter Hotez and the public health issue of online harassment

Biogen Alzheimer’s drug launch off to slow start

United colonoscopy coverage change 'may cost lives,' doctors say

How Vertex's cystic fibrosis drug is changing patients' lives

United colonoscopy coverage change 'may cost lives,' doctors say

Vaccine advisory panel ACIP left half staffed by HHS

The high cost of giving birth even with insurance

Experts study whether long Covid risk adds up with each reinfection

focus

Key House Republican on health care plans exit from Congress

Intarcia’s device

It's been 20 years since Dolly the sheep. Where's my clone?

Medicare threatens to cut off funding for HCA's Mission hospital

CDC advisers recommend seasonal use of Pfizer RSV shot

Medical student insurance fails on mental health care coverage

explore

leisure time

explore

hotspot